Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2011-05-24
2011-05-24
Skelding, Zachary (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S133100
Reexamination Certificate
active
07947272
ABSTRACT:
Inducing tolerance in a primate by use of a compound, or a combination of at least two compounds, that has certain characteristics when tested in vitro. The compound, alone or in combination, is preferably TRX1 antibody and the compound or combination is preferably used in accordance with a specified dosing regimen.
REFERENCES:
patent: 5690933 (1997-11-01), Cobbold et al.
patent: 6136310 (2000-10-01), Hanna et al.
patent: 6624186 (2003-09-01), Teuber et al.
patent: 2002/0187526 (2002-12-01), Ruben et al.
patent: 2004/0115166 (2004-06-01), Hayward et al.
patent: WO02/102853 (2002-12-01), None
Choy et al., Rheumatology (Oxford). Oct. 2002; 41(10):1142-8.
Hutchings et al., Eur J Immunol. Jul. 1992;22(7):1913-8.
Harper et al., Autoimmunity. 2001;33(4):245-51.
Cope, Arthritis Res. 2002;4 Suppl 3:S197-211. Epub May 9, 2002.
Zwacka et al., J Clin Invest. Jul. 15, 1997;100(2):279-89.
Wiendl et al., BioDrugs. 2002;16(3):183-200.
Van Oosten et al., Neurology. Aug. 1997;49(2):351-7.
O'Neill et al., J Neuroimmunol. Jun. 1993;45(1-2):1-14.
Koulmanda, et al., Cell Transportation, vol. 5, No. 5, Supp. 2, Supplement 2, Sep. 29-Oct. 2, 1996.
Rose, et al., Clin. Immunol. and Immunopathology, vol. 45, pp. 405-423 (1987).
Rose, et al., Annals New York Academy of Sciences, vol. 540, pp. 581-584 (1988).
Biasi, et al., J. Neuroimmunology, vol. 73, pp. 117-(23 (1997).
Cobbold Stephen
Frewin Mark
Gorman Scott
Hale Geoff
Kornaga Tadeusz
Cambridge University Technical Services Ltd.
ISIS Innovation, Ltd.
Lillie Raymond J.
Olstein Elliot M.
Skelding Zachary
LandOfFree
Compositions and methods of tolerizing a primate to an antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods of tolerizing a primate to an antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of tolerizing a primate to an antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2691160